UPXI (STOCKS)
Upexi, Inc. Common Stock
$1.200000
+0.060000 (+5.26%)
Prev close: $1.140000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Allan Marshall
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $83.91M
- Employees
- 59
- P/E (TTM)
- -0.23
- P/B (TTM)
- 1.55
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q2)
|
$-2.94 | $-0.05 | -2.8890 | -5,664.71% |
|
Sep 2025 (Q1)
|
$0.76 | $0.01 | +0.7498 | +7,350.98% |
|
Jun 2025 (Q4)
|
$-2.44 | $-0.07 | -2.3686 | -3,317.37% |
|
Mar 2024 (Q3)
|
$-4.00 | $-2.04 | -1.9600 | -96.08% |
Financial Statements
| Revenues | $24.74M |
| Benefits Costs and Expenses | $147.68M |
| Cost Of Revenue | $4.78M |
| Costs And Expenses | $147.68M |
| Gross Profit | $19.96M |
| Nonoperating Income/Loss | -$6.63M |
| Operating Expenses | $136.26M |
| Depreciation and Amortization | $567.58K |
| Other Operating Expenses | $135.69M |
| Operating Income/Loss | -$116.30M |
| Income/Loss From Continuing Operations After Tax | -$122.93M |
| Income/Loss From Continuing Operations Before Tax | -$122.93M |
| Income Tax Expense/Benefit | $13.56K |
| Interest And Dividend Income, Operating | -$6.92M |
| Interest Expense, Operating | $42.93K |
| Interest Income/Expense After Provision For Losses | -$6.96M |
| Interest Income/Expense Operating, Net | -$6.96M |
| Net Income/Loss | -$122.93M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$122.93M |
| Net Income/Loss Available To Common Stockholders, Basic | -$122.93M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$0.61 |
| Basic Average Shares | 66,194,760 |
| Diluted Average Shares | 66,194,760 |
| Assets | $271.14M |
| Current Assets | $171.25M |
| Inventory | $728.27K |
| Other Current Assets | $170.52M |
| Noncurrent Assets | $99.89M |
| Fixed Assets | $543.25K |
| Intangible Assets | $874.73K |
| Other Non-current Assets | $98.48M |
| Liabilities | $222.43M |
| Current Liabilities | $77.85M |
| Accounts Payable | $665.84K |
| Other Current Liabilities | $77.19M |
| Noncurrent Liabilities | $144.58M |
| Equity | $48.72M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $48.72M |
| Liabilities And Equity | $271.14M |
| Net Cash Flow From Operating Activities | -$17.53M |
| Net Cash Flow From Operating Activities, Continuing | -$17.53M |
| Net Cash Flow From Investing Activities | -$141.96M |
| Net Cash Flow From Investing Activities, Continuing | -$141.96M |
| Net Cash Flow From Financing Activities | $160.70M |
| Net Cash Flow From Financing Activities, Continuing | $160.70M |
| Net Cash Flow | $1.21M |
| Net Cash Flow, Continuing | $1.21M |
| Comprehensive Income/Loss | -$122.93M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$122.93M |
| Other Comprehensive Income/Loss | $0.00 |